This invention relates to novel cyclopropyl β-amino acids derivatives of the formula
wherein R1 through R4 are defined as in the specification, pharmaceutical compositions containing them and their use for the treatment of various central nervous system and other disorders. The cyclopropyl β-amino acids derivatives of this invention exhibit activity as alpha2delta ligands (α2δ ligands). Such compounds have affinity for the α2δ subunit of a calcium channel.
[EN] CYCLOPROPYL BETA-AMINO ACID DERIVATIVES<br/>[FR] DERIVES D'ACIDES BETA-AMINES DE CYCLOPROPYLE
申请人:WARNER LAMBERT CO
公开号:WO2004065361A2
公开(公告)日:2004-08-05
This invention relates to novel cyclopropyl β-amino acids derivatives of the formula (I) wherein R1 through R4 are defined as in the specification, pharmaceutical compositions containing them and their use for the treatment of various central nervous system and other disorders. The cyclopropyl β-amino acids derivatives of this invention exhibit activity as alpha2delta ligands (α2δ ligands). Such compounds have affinity for the α2δ subunit of a calcium channel.
Cyclopropyl beta-amino acid derivatives
申请人:——
公开号:US20040147608A1
公开(公告)日:2004-07-29
This invention relates to novel cyclopropyl &bgr;-amino acids derivatives of the formula
1
wherein R
1
through R
4
are defined as in the specification, pharmaceutical compositions containing them and their use for the treatment of various central nervous system and other disorders. The cyclopropyl &bgr;-amino acids derivatives of this invention exhibit activity as alpha2delta ligands (&agr;2&dgr; ligands). Such compounds have affinity for the &agr;2&dgr; subunit of a calcium channel.